InspireMD (NSPR) Current Leases (2021 - 2022)
InspireMD's (NSPR) quarterly Current Leases came in at $416000.0 in Q3 2022, down 0.95% quarter-over-quarter from $420000.0 in Q4 2021.
InspireMD (NSPR) Current Leases (2021 - 2022) Analysis & Trends
InspireMD's Current Leases history runs 2 years deep, the most recent figure standing at $416000.0 for Q3 2022.
- On a quarterly basis, Current Leases changed N/A year-over-year to $416000.0 in Q3 2022; TTM through Sep 2022 was $416000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $420000.0, changed N/A from the prior year.
- Current Leases eased to $416000.0 in Q3 2022 per NSPR's latest filing, from $420000.0 in the prior quarter.
- Across five years, Current Leases topped out at $420000.0 in Q4 2021 and bottomed at $416000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 20.50 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | - |
| 10 | InspireMD | 43.81 Mn | -10.41 Mn | 1.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 416,000.00 |
| Dec 31, 2021 | 420,000.00 |